Updated February 25, 2015.
There are always several drugs "in the pipeline" of development for psoriasis at any given time.Usually these are in some stage of FDA clinical trial testing.Many newer drugs are of the biologic class, but "upgrades" of older drugs and brand new classes of drugs are also under development.
ABT874 is a biologic drug that blocks chemicals called interleukins that aggravate psoriasis.More »
There are always several drugs "in the pipeline" of development for psoriasis at any given time.Usually these are in some stage of FDA clinical trial testing.Many newer drugs are of the biologic class, but "upgrades" of older drugs and brand new classes of drugs are also under development.
•ISA247 - A Cyclosporine like drug
ISA247 is a modified form of the drug cyclosporine with reduced negative effects on the patient.More »•ABT874 - A New Biologic Drug for Psoriasis
ABT874 is a biologic drug that blocks chemicals called interleukins that aggravate psoriasis.More »
•Ustekinumab - Biologic Drug with Quarterly Dosing
Ustekinumab is very exciting. Not only is it highly effective, but dosing is extremely convenient at one dose per quarter.More »
Source...